melatonin has been researched along with Acute Onset Vascular Dementia in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The current review aims to examine melatonin therapy for both sleep disturbances and cognitive function in dementia." | 8.91 | Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials. ( Chen, SD; Dammer, EB; Li, CB; Wang, G; Wang, LL; Xu, G; Xu, J, 2015) |
| "Neurodegenerative diseases are the second most common cause of death and characterized by progressive impairments in movement or mental functioning in the central or peripheral nervous system." | 6.66 | Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. ( Chen, D; Lee, TH; Zhang, T, 2020) |
| "The current review aims to examine melatonin therapy for both sleep disturbances and cognitive function in dementia." | 4.91 | Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials. ( Chen, SD; Dammer, EB; Li, CB; Wang, G; Wang, LL; Xu, G; Xu, J, 2015) |
| "Neurodegenerative diseases are the second most common cause of death and characterized by progressive impairments in movement or mental functioning in the central or peripheral nervous system." | 2.66 | Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases. ( Chen, D; Lee, TH; Zhang, T, 2020) |
| "Treatment with melatonin significantly increased OPN and SMP30 expression and ACh, NE, and Dop levels in the hippocampus with amelioration of the oxidative stress compared with BCCAO rats." | 1.48 | Melatonin ameliorates brain oxidative stress and upregulates senescence marker protein-30 and osteopontin in a rat model of vascular dementia. ( Bin-Jaliah, I; Sakr, HF, 2018) |
| "Thirteen elderly IPs with vascular dementia (mean age 76." | 1.33 | Passive body heating ameliorates sleep disturbances in patients with vascular dementia without circadian phase-shifting. ( Hishikawa, Y; Hozumi, S; Mishima, K; Mishima, Y; Shimizu, T, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Thangwong, P | 1 |
| Jearjaroen, P | 1 |
| Tocharus, C | 1 |
| Govitrapong, P | 1 |
| Tocharus, J | 1 |
| Chen, D | 1 |
| Zhang, T | 1 |
| Lee, TH | 1 |
| Shen, D | 1 |
| Tian, X | 1 |
| Sang, W | 1 |
| Song, R | 1 |
| Bin-Jaliah, I | 1 |
| Sakr, HF | 1 |
| Xu, J | 1 |
| Wang, LL | 1 |
| Dammer, EB | 1 |
| Li, CB | 1 |
| Xu, G | 1 |
| Chen, SD | 1 |
| Wang, G | 1 |
| Mishima, Y | 1 |
| Hozumi, S | 1 |
| Shimizu, T | 1 |
| Hishikawa, Y | 1 |
| Mishima, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Placebo-controlled Trial Evaluating the Effect of Melatonin on Sleep Quality in Patients With Dementia[NCT03066518] | Phase 4 | 40 participants (Actual) | Interventional | 2016-01-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for melatonin and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Circadian Rhythm; Dementia, Vascular; Hum | 2020 |
Melatonin for sleep disorders and cognition in dementia: a meta-analysis of randomized controlled trials.
Topics: Alzheimer Disease; Central Nervous System Depressants; Cognition; Cognition Disorders; Dementia; Dem | 2015 |
4 other studies available for melatonin and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Melatonin suppresses inflammation and blood‒brain barrier disruption in rats with vascular dementia possibly by activating the SIRT1/PGC-1α/PPARγ signaling pathway.
Topics: Animals; Blood-Brain Barrier; Dementia, Vascular; Inflammation; Male; Melatonin; PPAR gamma; Rats; R | 2023 |
Effect of Melatonin and Resveratrol against Memory Impairment and Hippocampal Damage in a Rat Model of Vascular Dementia.
Topics: Animals; Antioxidants; Brain-Derived Neurotrophic Factor; Dementia, Vascular; Disease Models, Animal | 2016 |
Melatonin ameliorates brain oxidative stress and upregulates senescence marker protein-30 and osteopontin in a rat model of vascular dementia.
Topics: Acetylcholine; Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Calcium-Binding Protein | 2018 |
Passive body heating ameliorates sleep disturbances in patients with vascular dementia without circadian phase-shifting.
Topics: Aged; Body Temperature Regulation; Circadian Rhythm; Dementia, Vascular; Female; Heating; Humans; Im | 2005 |